Most Popular Angioplasty Web Site
supported by Volcano Corporation
Volcano Corporation Schedules Events for
2008 TCT Transcatheter Cardiovascular Therapeutics Meeting

external sites:
Volcano Corporation

September 20, 2008 -- Volcano Corporation (Nasdaq: VOLC), a leading manufacturer of intravascular ultrasound (IVUS) and functional measurement (FM) technology, has scheduled several events to be held during the 2008 TCT meeting in Washington DC, being held October 12-17, 2008 at the Washington Convention Center.

A special evening symposium, titled "The Future of Intravascular Imaging: How IVUS, FFR, VH IVUS, CTO Imaging and OCT can improve everyday outcomes" will be held on Tuesday, October 14, at the Renaissance Washington, DC, Hotel, Renaissance Ballroom. Registration and a reception will start at 7:00pm, and at 8:00pm presentations by a number of prominent physicians will begin. To register for the evening symposium, email The scheduled talks are:

8:00pm The data supports more IVUS with DES
Augusto D. Pichard
Washington Hospital Center
Washington, DC USA

8:15pm Fast, simple, integrated IVUS. No more excuses
Matthew J. Price
Scripps Clinic
La Jolla, CA USA

8:25pm Fast, simple, integrated FFR. No more excuses
Morton J. Kern
University of California Irvine
Orange, CA USA

8:40pm VH IVUS and where it fits.
Steven P. Marso
St. Luke's Hospital
Kansas City, MO USA

8:55pm The potential of OCT
Giulio Guagliumi
Ospedali Riuniti Di Bergamo
Bergamo, Italy

9:10pm The practicality of OCT
Alexandre Abizaid
Instituto Dante Pazzanese de Cardiologia
Sao Paulo, Brazil

9:20pm CTO Imaging to give everyone access
David O. Williams
Rhode Island Hospital
Providence, RI USA

9:35pm Tying it all together with integration
Gary S. Mintz
Cardiovascular Research Foundation
New York, NY USA

9:45pm Panel Discussion

10:00pm Adjourn

Volcano Corporation will also be hosting an investor and analyst event on Tuesday, October 14, from 10:30-11:30am (ET) at the Grand Hyatt at Washington Center, 1000 H St., N.W., Conference Theatre. The keynote speaker will be Dr. Gus Pichard, Professor of Cardiology Medicine and Director of Cardiac Cath Labs at Washington Hospital Center. Dr. Pichard will discuss trends in the use of IVUS with drug-eluting stents, including the recently-introduced second generation devices. In addition, Scott Huennekens, president and chief executive officer, will provide a brief update on the company. A Q&A session will follow the formal presentations. For more information, please contact Cindy Birse at or (916) 281-2854.

Additionally Volcano will be exhibiting its latest technologies throughout the conference in the Exhibit Area on Level 2, Booth #1006.

About Volcano Corporation
Volcano Corporation offers a broad suite of devices designed to facilitate endovascular procedures, enhance the diagnosis of vascular and structural heart disease and guide optimal therapies. The company's intravascular ultrasound (IVUS) product line includes ultrasound consoles that can be integrated directly into virtually any modern cath lab. Volcano IVUS offers unique features, including both single-use phased array and rotational IVUS imaging catheters, and advanced functionality options, such as VH® IVUS tissue characterization and ChromaFlo®. Volcano also provides functional measurement (FM) consoles and single-use pressure and flow guide wires and is developing a line of ultra-high resolution Optical Coherence Tomography (OCT) and Forward Looking IVUS systems and catheters. Currently, more than 3,500 Volcano IVUS and FM systems are installed worldwide, with approximately half of its revenues coming from outside the United States. For more information, visit the company's website at

About the TCT
This year's Transcatheter Cardiovascular Therapeutics meeting marks a milestone: the 20th annual TCT. Created and managed by the Cardiovascular Research Foundation, based in New York, the TCT meeting has evolved over the past two decades into the premier interventional cardiology meeting, attended by 10,000 cardiologists and related professionals worldwide. Attendees will hear late-breaking clinical trial results, see live case demonstrations of innovative procedures beamed via satellite from cath labs around the the world, and will also get to visit and see the latest technologies in the Exhibition Hall, which occupies an entire floor of the Washington Convention Center. As of the 2009 annual meeting of the American College of Cardiology, the i2 Summit -- the ACC's special interventional section -- will be managed by the Cardiovascular Research Foundation. A complete program and other information about this year's meeting can be viewed on the TCT website at

Reported by Burt Cohen, September 20, 2008